Integrative multi-omics profiling deciphers tumor microenvironment heterogeneity and immunotherapy vulnerabilities in lung neuroendocrine carcinomas.

J Adv Res · 2026 · PMC12957838 · PMID 40513660

Europe PMC DOI

hedged sentence

0.0870

closest p · 1.7× alpha

0.0870

boldest claim

The sentences

marginally significantP = 0.087so close (0.05 < p ≤ 0.1)

In LCNEC patients, IPC2 tumors receiving chemotherapy after surgery were associated with a marginally significant DFS benefit compared to IPC1 tumors receiving chemotherapy (log-rank P = 0.087 ) and those not receiving chemotherapy after surgery (log-rank P = 0.075 ) ( Fig. 4 D).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.